Headache primary

Toxicity. Lethality is the primary ha2ard of phosphine exposure. Phosphine may be fatal if inhaled, swallowed, or absorbed through skin. AH phosphine-related effects seen at sublethal inhalation exposure concentrations are relatively small and completely reversible. The symptoms of sublethal phosphine inhalation exposure include headache, weakness, fatigue, di22iness, and tightness of the chest. Convulsions may be observed prior to death in response to high levels of phosphine inhalation. Some data are given in Table 2. 

Hydralazine. Hydrala2iae causes vasodilation ia all primary vascular beds and has more pronounced effects on capacitance than on resistance blood vessels. Despite the hypotension it produces, hydrala2iae iacreases renal blood flow and cardiac output. PRA iacreases with its use. Tachycardia, headache, di22iaess, and water and sodium retention are principal side effects of hydrala2iae therapy. 

Nicorandil. Nicorandil is a potassium channel opener that can lower blood pressure 21, 20, and 29 mm Hg after single oral doses of 10, 20, and 30 mg, respectively (250). There are no significant changes ia heart rate. Headache is the primary side effect. Nicorandil has potent coronary vasodilator effects. It causes sustained vasodilation of arteriolar resistance and venous capacitance blood vessels, thus reduciag cardiac preload and aftedoad. 

The patient is at risk for Stevens-Johnson syndrome when taking the cephalosporins StevensJohnson syndrome is manifested by fever, cough, muscular aches and pains headache, and the appearance of lesions on the skin, mucous membranes and eyes The lesions appear as red wheals or blisters often starting on the face, in the mouth, or on the lips neck, and extremities This syndrome, which also may occur with the administration of other types of drugs can be fatal. The nurse should report any of these symptoms to the primary health care provider immediately. 

Do not take diis drugwidi an antacid. In addition, avoid die use of nonprescription drag s unless use of a specific drug is approved by die primary health care provider. This drug may produce headache ... 

ISPHOSPHONATES The nurse monitors the patient taking the bisphosphonates for any adverse reactions such as nausea, diarrhea, increased or recurrent bone pain, headache dyspepsia, acid regurgitation, dysphagia, and abdominal pain. Analgesic maybe administered for headache Notify the primary health care provider of adverse reactions such as the return of bone pain or severe diarrhea... 

Local irritation and headache may occur at tlie beginning of therapy. The patient is instructed to notify the primary health care provider if abdominal cramping, diarrhea, or excessive salivation occurs. 

Notify the primary healdi care provider if any of the following occurs skin rash, bleeding, swollen or tender gums, yellowish discoloration of the skin or eyes, unexplained fever, sore throat, unusual bleeding or bruising, persistent headache, malaise, or pregnancy. 

Complaints of a headache (especially an ocdpital headache) may indicate the occurrence of a hypertensive criss. The nurse should take the blood pressure and, if it is elevated, notify the primary health care provider immediately. The nurse should monitor the blood pressure at 15- to 30-minute intervals. The primary health care provider must be notified of any additional symptoms of hypertensive crisis. 

Notify the primary health care provider immediately if any of the following signs of theophylline toxicity develop anorexia, nausea, vomiting, diarrhea, confusion, abdominal cramping, headache, restlessness insomnia, tachycardia, arrhythmias or seizures... 

Contact the primary care provider if palpitations, tachycardia, chest pain, muscle tremors, dizziness, headache, flushing, or difficulty with urination or breatliing occur. 

The nurse should advise the patient taking a nonprescription cough medicine that if a cough lasts more than 10 days or is accompanied by fever, chest pain, severe headache, or skin rash, the patient should consult the primary health care provider. 

During initial therapy, headache and postural hypotension may occur, and the nurse must notify the primary health care provider because a dose change may be necessary. The nurse assists patients having episodes of postural hypotension with all ambulatory activities. The nurse instructs those with episodes of postural hypotension to take the drug in a sitting or supine position and to remain in that position until symptoms disappear. Hypotension maybe accompanied by paradoxical... 

Headache is a common adverse reaction but should decrease widi continued therapy. If headache persists or becomes severe, notify die primary healdi care provider because a change in dosage may be needed. In patients who get headaches, die headaches may be a marker of the drug s effectiveness. Fhtients should not try to avoid headaches by altering die treatment schedule because loss of headache may be associated with simultaneous loss of drug effectiveness. Aspirin or acetaminophen may be used for headache relief. 

If nausea, vomiting, or diarrhea occurs, contact tiie primary health care provider. These drug may also cause flushing, sweating, headache, tiredness, jaundice, skin rash, anorexia, and abdominal distress. Notify tiie primary health care provider if these effects become pronounced. 

Notify the primary health care provider if bloating, stomach or pelvic pain, jaundice, blurred vision, hot flashes, breast discomfort, headache, nausea, or vomiting occurs. 

Notify die primary health care provider of a marked weight gain, swelling in the extremities, muscle weakness, persistent headache, visual disturbances, or behavior change... 

Bccesave dosage is manifested as water intoxication (fluid overload). Symptoms of water intoxication include drowsiness, listlessness confusion, and headache (which may precede convulsions and coma). If sgns of excessive dosage occur, the nurse should notify the primary health care provider before the next dose of the drug is due because a change in the dosage, the restriction of oral or IV fluids and the administration of a diuretic may be necessary. 

Contact the primary health care provider immediately if any of the following occur a significant increase or decrease in urinary output, abdominal cramps, blanching of the skin, nausea, signs of inflammation or infection at the injection sites, confusion, headache, or drowsiness. 

Inform the primary healdi care provider if the following adverse reactions occur edema, muscle weakness, weight gain, anorexia, swelling of the extremities, dizziness, severe headache, or shortness of breath. 

Notify the primary healtii care provider if any of the following occur headache, nervousness, palpitations, diarrhea, excessive sweating, heat intolerance, chest pain, increased pulse rate, or any unusual physical change or event. 

Agranulocytosis is potentially the most serious adverse reaction to methimazole and propylthiouracil. The nurse notifies the primary health care provider if fever, sore throat, rash, headache, hay fever, yellow discoloration of the skin, or vomiting occurs. 

Notify the primary health care provider promptly if any of the following occur sore throat, fever, cough, easy bleeding or bruising, headache, or a general feeling of malaise... 

MANAGING THROMOOEMOOLIC EFFECTS. The nurse monitors the patient for signs of thromboembolic effects, such as pain, swelling, tenderness in die extremities, headache, chest pain, and blurred vision. These adverse effects are reported to die primary health care provider. Patients with previous venous insufficiency, who are on bed rest for other medical reasons, or who smoke are at increased risk for tiiromboembolic effects. The nurse encourages the patient to elevate the lower extremities when sitting, if possible, and to exercise the lower extremities by walking. 

Notify the primary health care provider if any of the following occurs pain in the legs or groin area, sharp chest pain or sudden shortness of breatii, lumps in die breast, sudden severe headache, dizziness or fainting, vision or speech disturbances, weakness or numbness in the arms or legp, severe abdominal pain, depression, or yellowing of die skin or eyes. 

The nurse immediately reports any signs of water intoxication or fluid overload (eg, drowsiness, confusion, headache, listlessness, and wheezing, coughing, rapid breathing) to the primary health care provider. 

If oral terbutaline is prescribed for preterm labor, die patient is instructed on use of die drug and adverse reactions to report (excessive tremor, nervousness, drowsiness, headache, nausea, dizziness). If contractions resume during oral dierapy, die patient is instructed to notify die primary healdi care provider if four to six contractions per hour occur. 

During the first 30 minutes of infusion of a fat solution, the nurse carefully observesthe patient for difficulty in breathing, headache, flushing, nausea, vomiting, or signs of a hypersensitivity reaction. If any of these reactions occur, the nurse dis-continuesthe inf us on and immediately notifies the primary health care provider. 

Gnkgo (maiden hair tree, kew tree) Ginkgo biloba Raynauds disease, cerebral insufficiency anxiety, stress, tinnitus, dementias, circulatory problems, asthma Rare if used as directed possible effects include headache, dizziness, heart palpitations, Gl effects, rash, allergic dermatitis Do not take with antidepressant drugs, such as the MAOIs, or the antiplatelet drugs such as coumarin, unless advised to do so by the primary care provider. 

Side effects. The primary side effects reported with bupropion administration in cigarette smokers are headache, dry mouth, nausea and vomiting, insomnia, and activation. Although most of these adverse effects occur during the first week of treatment, insomnia can persist. Seizures are of exceedingly low occurrence (<0.5%) at doses of 300 mg daily or less, but a prior history of seizures or a seizure disorder contraindicate its use. 

In the past, trichloroethylene was used as a human anesthetic. Trichloroethylene has also been used by individuals who intentionally inhale it for its narcotic properties. Therefore, most of the information regarding the effects of trichloroethylene in humans comes from case studies and experiments describing effects of trichloroethylene after inhalation exposure. These studies indicate that the primary effect of exposure to trichloroethylene is on the central nervous system. Effects include headache, vertigo, fatigue, short-term memory loss, decreased word associations, central nervous system depression, and anesthesia. 

---